Impact of Short-Acting Disopyramide on Left Ventricular Mechanics Evaluated by Strain Analysis in Patients with Hypertrophic Obstructive Cardiomyopathy

Background: Disopyramide is a class Ia antiarrhythmic drug that has been used for the second-line treatment of symptomatic hypertrophic obstructive cardiomyopathy (HOCM). The aim of the study was to assess the impact of short-acting disopyramide in patients with hypertrophic obstructive cardiomyopat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yedidya, Idit, Elbaz Greener, Gabby, Vaturi, Mordehay, Sagie, Alik, Amir, Offer, Carasso, Shemy, Monakier, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785974/
https://www.ncbi.nlm.nih.gov/pubmed/36555940
http://dx.doi.org/10.3390/jcm11247325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785974/
https://www.ncbi.nlm.nih.gov/pubmed/36555940
http://dx.doi.org/10.3390/jcm11247325

Ejemplares similares